# Krishna Institute of Medical Sciences Ltd (KIMS)
> Exchange: NSE | Sector: Pharma | ISIN: 

## Price
Current Price: ₹769.15
Day Change: +1.77%
52W High: ₹798.4
52W Low: ₹575.8
Market Cap: ₹28,970 Cr

## Valuation
P/E: 96.02
P/B: 12.76
EPS: ₹7.54
Book Value: ₹56.74
Dividend Yield: 0%

## Returns
1Y Return: 4.28%

## Profitability
ROE: 9.72%
ROCE: 17.05%
Debt/Equity: 1.66
Revenue Growth: 36%
Profit Growth: -58.3%
EBITDA Margin: 21.07%
Operating Margin: 12.1%

## About
Krishna Institute of Medical Sciences Ltd is a Medical Care Facilities company listed on NSE. The page combines exchange quotes, financial statements, shareholding, filings, and news so investors can review the business in one place.
Sector: Pharma
Industry: Medical Care Facilities
Sub Industry: Unknown

## Business Model
Overview: Krishna Institute of Medical Sciences Ltd makes money through Domestic formulations, Exports and regulated markets, Specialty or institutional sales in Medical Care Facilities. Revenue quality depends on demand growth, margin discipline, balance-sheet strength, and the company's ability to defend its position within Pharma.
Source: Derived from stock data
Revenue Streams:
- Domestic formulations
- Exports and regulated markets
- Specialty or institutional sales
Operating Model:
- Develops, manufactures, distributes, or services healthcare products across regulated channels.
- Approvals, product mix, compliance quality, and R&D productivity shape growth.
Recent Context:
- Announcement: Announcement under Regulation 30 (LODR)-Press Release / Media Release
- Investor Presentation: Announcement under Regulation 30 (LODR)-Investor Presentation
- BSE Filing: Announcement under Regulation 30 (LODR)-Press Release / Media Release

## Access
Current tier: anonymous
More history: Register free to see 7 more years.

## Data Freshness
Quote Updated: 2026-05-21T20:00:02.224Z
Price History Updated: 2026-05-18T22:58:12.836Z
Latest Price History Date: 2026-05-18
Technicals Updated: 2026-05-18T22:58:12.836Z
Quant Updated: 2026-05-18T22:58:12.836Z
Sentiment Updated: 2026-05-18T22:58:12.836Z
Financials Status: current
Financials Updated: 2026-05-18T08:30:44.249Z
Financials Last Attempt: 2026-05-18T08:30:44.249Z
Financials Provider Tried: yahoo
Latest P&L Period: FY25
Latest Balance Sheet Period: FY25
Latest Cash Flow Period: FY25

## P&L (Mar 2017)
Revenue: ₹512 Cr
Operating Profit: ₹109 Cr (OPM 21%)
Net Profit: ₹28 Cr
Tax: ₹41 Cr

## Annual P&L History
Mar 2017: Rev ₹512Cr | PAT ₹28Cr | OPM 21%
Mar 2018: Rev ₹567Cr | PAT ₹33Cr | OPM 21%
Mar 2019: Rev ₹664Cr | PAT ₹-46Cr | OPM 11%

## Balance Sheet (Mar 2017)
Total Assets: ₹665 Cr
Total Liabilities: ₹665 Cr
Borrowings: ₹256 Cr
Cash: ₹undefined Cr

## Shareholding
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%
undefined: undefined%

## Board
- Bhaskara Rao Bollineni, Founder, MD & Executive Chairman
- Abhinay  Bollineni, CEO & Executive Director
- Sachin Ashok Salvi, Chief Financial Officer
- Juttur Raghavendradas Nagajayanthi, Company Secretary, Compliance Officer & General Counsel
- Sreenath Pocha Reddy CA, LLB, Cluster Head for the Karnataka cluster

---
Source: rupiya.io/stocks/kims
Disclaimer: For research and education only. Not investment advice.